

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 6.33368970 |
| 2 | interferon-gamma secretion (GO:0072643) | 5.70788519 |
| 3 | intestinal epithelial cell development (GO:0060576) | 5.52272829 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.51685172 |
| 5 | fructose metabolic process (GO:0006000) | 5.49982934 |
| 6 | regulation of cellular amino acid metabolic process (GO:0006521) | 5.44135088 |
| 7 | folic acid metabolic process (GO:0046655) | 5.40541923 |
| 8 | ribosome assembly (GO:0042255) | 5.38864469 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 5.28431649 |
| 10 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 5.27626060 |
| 11 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 5.25166229 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.20592032 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.20592032 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.13493118 |
| 15 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 5.12663586 |
| 16 | purine nucleobase biosynthetic process (GO:0009113) | 4.91963984 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85849261 |
| 18 | folic acid transport (GO:0015884) | 4.82867366 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.79375738 |
| 20 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.75681376 |
| 21 | negative regulation of ligase activity (GO:0051352) | 4.74586753 |
| 22 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.74586753 |
| 23 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.71010072 |
| 24 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.71010072 |
| 25 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.69577710 |
| 26 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.69577710 |
| 27 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.69577710 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.63039220 |
| 29 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.62521359 |
| 30 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.61851008 |
| 31 | nucleobase biosynthetic process (GO:0046112) | 4.58499796 |
| 32 | rRNA modification (GO:0000154) | 4.55339461 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52876330 |
| 34 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.51843938 |
| 35 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.51843938 |
| 36 | cellular extravasation (GO:0045123) | 4.51047966 |
| 37 | positive regulation of ligase activity (GO:0051351) | 4.49919359 |
| 38 | regulation of histone H3-K27 methylation (GO:0061085) | 4.44810610 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.25519338 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.25519338 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 4.25519338 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 4.25519338 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 4.25519338 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.25519338 |
| 45 | amino sugar catabolic process (GO:0046348) | 4.25445069 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 4.17947452 |
| 47 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.13553707 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.10342493 |
| 49 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 4.09695244 |
| 50 | lung-associated mesenchyme development (GO:0060484) | 4.09571559 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.09326350 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05712154 |
| 53 | mitotic metaphase plate congression (GO:0007080) | 4.01028167 |
| 54 | regulation of cellular amine metabolic process (GO:0033238) | 3.96151749 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 3.94066585 |
| 56 | regulation of ligase activity (GO:0051340) | 3.90934387 |
| 57 | formation of translation preinitiation complex (GO:0001731) | 3.89332948 |
| 58 | positive regulation of cell cycle arrest (GO:0071158) | 3.88060781 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.86472870 |
| 60 | detection of other organism (GO:0098543) | 3.82537984 |
| 61 | response to type I interferon (GO:0034340) | 3.79682501 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.79290511 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.75597915 |
| 64 | cellular response to type I interferon (GO:0071357) | 3.75597915 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.73489749 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.73267692 |
| 67 | L-methionine salvage (GO:0071267) | 3.71045030 |
| 68 | L-methionine biosynthetic process (GO:0071265) | 3.71045030 |
| 69 | amino acid salvage (GO:0043102) | 3.71045030 |
| 70 | response to peptidoglycan (GO:0032494) | 3.69238398 |
| 71 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.68680167 |
| 72 | detection of bacterium (GO:0016045) | 3.63343555 |
| 73 | negative thymic T cell selection (GO:0045060) | 3.61993270 |
| 74 | negative T cell selection (GO:0043383) | 3.61126144 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.58369407 |
| 76 | DNA replication checkpoint (GO:0000076) | 3.58059477 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56363201 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.54437305 |
| 79 | regulation of translation in response to stress (GO:0043555) | 3.53719951 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 3.51998836 |
| 81 | detection of molecule of bacterial origin (GO:0032490) | 3.51865279 |
| 82 | microglial cell activation (GO:0001774) | 3.50802184 |
| 83 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.50585765 |
| 84 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.49029103 |
| 85 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.48151073 |
| 86 | N-acetylneuraminate metabolic process (GO:0006054) | 3.46067176 |
| 87 | detection of external biotic stimulus (GO:0098581) | 3.45022601 |
| 88 | T cell migration (GO:0072678) | 3.44876333 |
| 89 | blastocyst development (GO:0001824) | 3.44545957 |
| 90 | positive thymic T cell selection (GO:0045059) | 3.43537847 |
| 91 | ribosome biogenesis (GO:0042254) | 3.42795179 |
| 92 | modified amino acid transport (GO:0072337) | 3.42559155 |
| 93 | DNA deamination (GO:0045006) | 3.41821641 |
| 94 | maturation of 5.8S rRNA (GO:0000460) | 3.40401880 |
| 95 | GDP-mannose metabolic process (GO:0019673) | 3.36428355 |
| 96 | regulation of mitochondrial translation (GO:0070129) | 3.35999842 |
| 97 | ADP metabolic process (GO:0046031) | 3.35970282 |
| 98 | positive regulation of interferon-alpha production (GO:0032727) | 3.32031871 |
| 99 | cell cycle G1/S phase transition (GO:0044843) | 3.31320798 |
| 100 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.31320798 |
| 101 | response to interleukin-15 (GO:0070672) | 3.31019541 |
| 102 | regulation of translational termination (GO:0006449) | 3.30659118 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 3.28487616 |
| 104 | negative regulation of protein ubiquitination (GO:0031397) | 3.26482619 |
| 105 | intestinal absorption (GO:0050892) | 3.26451378 |
| 106 | cyclooxygenase pathway (GO:0019371) | 3.26230681 |
| 107 | oligosaccharide catabolic process (GO:0009313) | 3.23184939 |
| 108 | germinal center formation (GO:0002467) | 3.23054313 |
| 109 | leukocyte aggregation (GO:0070486) | 3.22988208 |
| 110 | regulation of interferon-alpha production (GO:0032647) | 3.21978168 |
| 111 | regulation of B cell differentiation (GO:0045577) | 3.20938690 |
| 112 | cellular response to interleukin-15 (GO:0071350) | 3.20509753 |
| 113 | positive regulation of B cell differentiation (GO:0045579) | 3.20084919 |
| 114 | B cell mediated immunity (GO:0019724) | 3.19910349 |
| 115 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.17169029 |
| 116 | signal transduction in response to DNA damage (GO:0042770) | 3.16905372 |
| 117 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.16778904 |
| 118 | keratinocyte development (GO:0003334) | 3.14468730 |
| 119 | positive T cell selection (GO:0043368) | 3.14256764 |
| 120 | neutrophil activation (GO:0042119) | 3.12939499 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.12839367 |
| 122 | regulation of cell cycle arrest (GO:0071156) | 3.11891384 |
| 123 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10556713 |
| 124 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10001247 |
| 125 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09542256 |
| 126 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.09025666 |
| 127 | rRNA methylation (GO:0031167) | 3.08831072 |
| 128 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.08296290 |
| 129 | defense response to protozoan (GO:0042832) | 3.08080242 |
| 130 | regulation of regulatory T cell differentiation (GO:0045589) | 3.06805034 |
| 131 | methionine metabolic process (GO:0006555) | 3.06486830 |
| 132 | methionine biosynthetic process (GO:0009086) | 3.06250286 |
| 133 | macrophage activation (GO:0042116) | 3.06080336 |
| 134 | 7-methylguanosine mRNA capping (GO:0006370) | 3.05348816 |
| 135 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 3.05257058 |
| 136 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 3.05257058 |
| 137 | response to host immune response (GO:0052572) | 3.05253512 |
| 138 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05253512 |
| 139 | DNA damage induced protein phosphorylation (GO:0006975) | 3.03831124 |
| 140 | positive regulation of mast cell activation (GO:0033005) | 3.03702718 |
| 141 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.03157144 |
| 142 | regulation of mast cell activation (GO:0033003) | 3.01752077 |
| 143 | NADH metabolic process (GO:0006734) | 3.01389047 |
| 144 | detection of biotic stimulus (GO:0009595) | 3.01245412 |
| 145 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99916529 |
| 146 | DNA damage response, detection of DNA damage (GO:0042769) | 2.99067339 |
| 147 | metaphase plate congression (GO:0051310) | 2.98795990 |
| 148 | mast cell activation (GO:0045576) | 2.97702364 |
| 149 | sulfur amino acid biosynthetic process (GO:0000097) | 2.97701955 |
| 150 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.97135290 |
| 151 | neutrophil mediated immunity (GO:0002446) | 2.96722774 |
| 152 | cellular response to exogenous dsRNA (GO:0071360) | 2.96068640 |
| 153 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96029739 |
| 154 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95765657 |
| 155 | regulation of germinal center formation (GO:0002634) | 2.95730365 |
| 156 | galactose catabolic process (GO:0019388) | 2.95249213 |
| 157 | regulation of T cell tolerance induction (GO:0002664) | 2.94396850 |
| 158 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93395790 |
| 159 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93395790 |
| 160 | termination of RNA polymerase I transcription (GO:0006363) | 2.93064165 |
| 161 | tolerance induction (GO:0002507) | 2.91854725 |
| 162 | respiratory burst (GO:0045730) | 2.91656832 |
| 163 | response to protozoan (GO:0001562) | 2.90790497 |
| 164 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90689940 |
| 165 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.90237522 |
| 166 | meiosis I (GO:0007127) | 2.89276739 |
| 167 | positive regulation of interferon-beta production (GO:0032728) | 2.88775876 |
| 168 | granulocyte activation (GO:0036230) | 2.88611870 |
| 169 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88419078 |
| 170 | regulation of tolerance induction (GO:0002643) | 2.88320299 |
| 171 | RNA capping (GO:0036260) | 2.87618825 |
| 172 | 7-methylguanosine RNA capping (GO:0009452) | 2.87618825 |
| 173 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87366119 |
| 174 | activated T cell proliferation (GO:0050798) | 2.87211532 |
| 175 | termination of RNA polymerase III transcription (GO:0006386) | 2.86447524 |
| 176 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.86447524 |
| 177 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.86063823 |
| 178 | regulation of spindle organization (GO:0090224) | 2.85785116 |
| 179 | T cell selection (GO:0045058) | 2.85603293 |
| 180 | transcription from RNA polymerase I promoter (GO:0006360) | 2.84743449 |
| 181 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.82828464 |
| 182 | interferon-gamma production (GO:0032609) | 2.82485438 |
| 183 | ribosomal large subunit biogenesis (GO:0042273) | 2.82453793 |
| 184 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81802085 |
| 185 | establishment of chromosome localization (GO:0051303) | 2.81740556 |
| 186 | response to host (GO:0075136) | 2.81511736 |
| 187 | response to host defenses (GO:0052200) | 2.81511736 |
| 188 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81511736 |
| 189 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.80934985 |
| 190 | protein localization to kinetochore (GO:0034501) | 2.80365954 |
| 191 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.79392267 |
| 192 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.79377930 |
| 193 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79070064 |
| 194 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.78561303 |
| 195 | leukocyte degranulation (GO:0043299) | 2.78422870 |
| 196 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.77118309 |
| 197 | CENP-A containing nucleosome assembly (GO:0034080) | 2.77088919 |
| 198 | regulation of mast cell degranulation (GO:0043304) | 2.74083727 |
| 199 | negative regulation of innate immune response (GO:0045824) | 2.73999797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.76875477 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.64110854 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.45918019 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.28653576 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27785165 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.13084863 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.90572915 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.90177390 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.82505769 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.82000690 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.74002082 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.70938255 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.56532019 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.52165743 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.49905032 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.45802574 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.13429314 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.13130054 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08387119 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.98778685 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95048562 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.91799668 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.76414984 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76016409 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.68574971 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.68507055 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.62148194 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.61325269 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.51336082 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 2.49681950 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.49678998 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.47380078 |
| 33 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.46153727 |
| 34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.44036734 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.30246658 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.29823652 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27929018 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27205749 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.26171058 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.23928083 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23029487 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19112809 |
| 43 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.18702795 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18304803 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08948824 |
| 46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.05711503 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.05459514 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.04571236 |
| 49 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.03607290 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02768741 |
| 51 | * MYB_26560356_Chip-Seq_TH1_Human | 2.02304195 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.02297563 |
| 53 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.00060341 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94592941 |
| 55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.94492915 |
| 56 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.92745982 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92196607 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.91937019 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.91624689 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.90517815 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86460557 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85782542 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85164414 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83641496 |
| 65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81999925 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.77565950 |
| 67 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.76236265 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.75039132 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.73420750 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72988297 |
| 71 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66808860 |
| 72 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.59131992 |
| 73 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.57110032 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56365441 |
| 75 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.56293563 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55468897 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53680693 |
| 78 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.52760156 |
| 79 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.51349912 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51105898 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51085186 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50913559 |
| 83 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.50784927 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50092287 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48283391 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47908571 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.45670121 |
| 88 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45524231 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.44839493 |
| 90 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.44818127 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44108730 |
| 92 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.44077436 |
| 93 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42387519 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41184871 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40667259 |
| 96 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38309629 |
| 97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37403109 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37237112 |
| 99 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.36773211 |
| 100 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35251651 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.32039441 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31403105 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30782957 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30588727 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30136909 |
| 106 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.27717466 |
| 107 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26711373 |
| 108 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26160494 |
| 109 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23741584 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22651534 |
| 111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21396666 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21010244 |
| 113 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19274367 |
| 114 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.19011559 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18688999 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18154492 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.17380030 |
| 118 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16995665 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15501650 |
| 120 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.15401705 |
| 121 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15177959 |
| 122 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13915301 |
| 123 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.13040264 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12925694 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12792858 |
| 126 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12408915 |
| 127 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12272264 |
| 128 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10896381 |
| 129 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10248147 |
| 130 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09642797 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09134083 |
| 132 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07717587 |
| 133 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.04976664 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04949635 |
| 135 | MYC_22102868_ChIP-Seq_BL_Human | 1.04898833 |
| 136 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.04510354 |
| 137 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04413481 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02420271 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00905193 |
| 140 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.00536162 |
| 141 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99148463 |
| 142 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98951099 |
| 143 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98856828 |
| 144 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.98218348 |
| 145 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98100861 |
| 146 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97734566 |
| 147 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95956018 |
| 148 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.94940610 |
| 149 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94061435 |
| 150 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91168461 |
| 151 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91082298 |
| 152 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91019296 |
| 153 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90894765 |
| 154 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90425218 |
| 155 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89949518 |
| 156 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89196730 |
| 157 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89123884 |
| 158 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87999213 |
| 159 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87978026 |
| 160 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.87580496 |
| 161 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86263423 |
| 162 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86035569 |
| 163 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.85866788 |
| 164 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85565811 |
| 165 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85204525 |
| 166 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84439391 |
| 167 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.84363501 |
| 168 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84203967 |
| 169 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.83966408 |
| 170 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83225224 |
| 171 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.81611862 |
| 172 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.80664313 |
| 173 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.80265187 |
| 174 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.79925578 |
| 175 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.79074708 |
| 176 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.79074708 |
| 177 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78170329 |
| 178 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76989765 |
| 179 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76764187 |
| 180 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76288125 |
| 181 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75984481 |
| 182 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.75777752 |
| 183 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75536301 |
| 184 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74102451 |
| 185 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74004405 |
| 186 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73933998 |
| 187 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71511325 |
| 188 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71422184 |
| 189 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70712169 |
| 190 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.70223415 |
| 191 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.68678372 |
| 192 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.67469969 |
| 193 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67433219 |
| 194 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.67259694 |
| 195 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.66677144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.56447947 |
| 2 | MP0003718_maternal_effect | 4.92109879 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.53911141 |
| 4 | MP0001835_abnormal_antigen_presentation | 4.36573950 |
| 5 | MP0003724_increased_susceptibility_to | 4.35929340 |
| 6 | MP0009840_abnormal_foam_cell | 4.32392104 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.98765068 |
| 8 | MP0003436_decreased_susceptibility_to | 3.63994007 |
| 9 | MP0005671_abnormal_response_to | 3.26794550 |
| 10 | MP0008260_abnormal_autophagy | 3.21490934 |
| 11 | MP0000685_abnormal_immune_system | 3.19191601 |
| 12 | MP0001800_abnormal_humoral_immune | 3.18080928 |
| 13 | MP0005387_immune_system_phenotype | 3.03813013 |
| 14 | MP0001790_abnormal_immune_system | 3.03813013 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 3.01326629 |
| 16 | MP0009785_altered_susceptibility_to | 2.92130246 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.90052344 |
| 18 | MP0005360_urolithiasis | 2.86897327 |
| 19 | MP0003303_peritoneal_inflammation | 2.86733492 |
| 20 | MP0003878_abnormal_ear_physiology | 2.81726413 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 2.81726413 |
| 22 | MP0002419_abnormal_innate_immunity | 2.76769521 |
| 23 | MP0005451_abnormal_body_composition | 2.71288540 |
| 24 | MP0002723_abnormal_immune_serum | 2.69360724 |
| 25 | MP0005025_abnormal_response_to | 2.68874809 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.66598535 |
| 27 | MP0003077_abnormal_cell_cycle | 2.66172693 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.65608392 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.62540171 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.48339333 |
| 31 | MP0001819_abnormal_immune_cell | 2.45979178 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 2.40155778 |
| 33 | MP0010094_abnormal_chromosome_stability | 2.37702344 |
| 34 | MP0001666_abnormal_nutrient_absorption | 2.28606812 |
| 35 | MP0006082_CNS_inflammation | 2.25812546 |
| 36 | MP0008932_abnormal_embryonic_tissue | 2.22280241 |
| 37 | MP0005395_other_phenotype | 2.10423654 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 2.03743837 |
| 39 | MP0008058_abnormal_DNA_repair | 1.99688539 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.96816235 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.96200831 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.94251374 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.94232491 |
| 44 | MP0002405_respiratory_system_inflammati | 1.93099880 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.91656821 |
| 46 | MP0000716_abnormal_immune_system | 1.88009243 |
| 47 | MP0002398_abnormal_bone_marrow | 1.87681793 |
| 48 | MP0003315_abnormal_perineum_morphology | 1.87074697 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.80574865 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.80183108 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.79757332 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.79745857 |
| 53 | MP0005670_abnormal_white_adipose | 1.78783233 |
| 54 | MP0004947_skin_inflammation | 1.78218033 |
| 55 | MP0001730_embryonic_growth_arrest | 1.77675854 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.72392187 |
| 57 | MP0003786_premature_aging | 1.71357369 |
| 58 | MP0009764_decreased_sensitivity_to | 1.66432866 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.65354949 |
| 60 | MP0003646_muscle_fatigue | 1.65258962 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.64542163 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.62918835 |
| 63 | MP0000569_abnormal_digit_pigmentation | 1.59557537 |
| 64 | MP0005310_abnormal_salivary_gland | 1.52921323 |
| 65 | MP0002722_abnormal_immune_system | 1.51773487 |
| 66 | MP0000490_abnormal_crypts_of | 1.51411638 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.51345261 |
| 68 | MP0002006_tumorigenesis | 1.49775180 |
| 69 | MP0008057_abnormal_DNA_replication | 1.45631137 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.44280269 |
| 71 | MP0002429_abnormal_blood_cell | 1.43828484 |
| 72 | MP0003567_abnormal_fetal_cardiomyocyte | 1.41321461 |
| 73 | MP0008469_abnormal_protein_level | 1.40552256 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.38432310 |
| 75 | MP0003045_fibrosis | 1.33452297 |
| 76 | MP0005332_abnormal_amino_acid | 1.32794679 |
| 77 | MP0001727_abnormal_embryo_implantation | 1.31551036 |
| 78 | MP0001853_heart_inflammation | 1.30300871 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.28311790 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.27774660 |
| 81 | MP0003329_amyloid_beta_deposits | 1.27542307 |
| 82 | MP0003828_pulmonary_edema | 1.26931267 |
| 83 | MP0004883_abnormal_blood_vessel | 1.25825003 |
| 84 | MP0009697_abnormal_copulation | 1.24715157 |
| 85 | MP0005085_abnormal_gallbladder_physiolo | 1.21704928 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 1.21584309 |
| 87 | MP0003866_abnormal_defecation | 1.21126698 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 1.20502148 |
| 89 | MP0001873_stomach_inflammation | 1.18758531 |
| 90 | MP0002933_joint_inflammation | 1.17558723 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.16758416 |
| 92 | MP0002998_abnormal_bone_remodeling | 1.16556517 |
| 93 | MP0005164_abnormal_response_to | 1.15502361 |
| 94 | MP0009278_abnormal_bone_marrow | 1.13972448 |
| 95 | MP0000350_abnormal_cell_proliferation | 1.12590440 |
| 96 | MP0001851_eye_inflammation | 1.11890481 |
| 97 | MP0002132_abnormal_respiratory_system | 1.11875777 |
| 98 | MP0003938_abnormal_ear_development | 1.11700008 |
| 99 | MP0001756_abnormal_urination | 1.11195659 |
| 100 | MP0001672_abnormal_embryogenesis/_devel | 1.09452012 |
| 101 | MP0005380_embryogenesis_phenotype | 1.09452012 |
| 102 | MP0008007_abnormal_cellular_replicative | 1.09317363 |
| 103 | MP0003879_abnormal_hair_cell | 1.08151917 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 1.04482383 |
| 105 | MP0002080_prenatal_lethality | 0.99073801 |
| 106 | MP0003699_abnormal_female_reproductive | 0.98770488 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.98247881 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 0.97779890 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.97383282 |
| 110 | MP0000477_abnormal_intestine_morphology | 0.96359691 |
| 111 | MP0000858_altered_metastatic_potential | 0.95423957 |
| 112 | MP0003252_abnormal_bile_duct | 0.93852835 |
| 113 | MP0005389_reproductive_system_phenotype | 0.93395177 |
| 114 | MP0001929_abnormal_gametogenesis | 0.91704032 |
| 115 | MP0001919_abnormal_reproductive_system | 0.91369540 |
| 116 | MP0005621_abnormal_cell_physiology | 0.91305216 |
| 117 | MP0002210_abnormal_sex_determination | 0.90705132 |
| 118 | MP0001542_abnormal_bone_strength | 0.90674141 |
| 119 | MP0001697_abnormal_embryo_size | 0.90003922 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.89109464 |
| 121 | MP0003195_calcinosis | 0.88799775 |
| 122 | MP0000462_abnormal_digestive_system | 0.88480135 |
| 123 | MP0003075_altered_response_to | 0.88475781 |
| 124 | MP0000358_abnormal_cell_content/ | 0.88208591 |
| 125 | MP0009763_increased_sensitivity_to | 0.88029814 |
| 126 | MP0005166_decreased_susceptibility_to | 0.87827436 |
| 127 | MP0003186_abnormal_redox_activity | 0.87543704 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 0.87321391 |
| 129 | MP0000627_abnormal_mammary_gland | 0.87300164 |
| 130 | MP0003984_embryonic_growth_retardation | 0.85653554 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.85520962 |
| 132 | MP0001764_abnormal_homeostasis | 0.84956416 |
| 133 | MP0001440_abnormal_grooming_behavior | 0.83015663 |
| 134 | MP0002277_abnormal_respiratory_mucosa | 0.82854386 |
| 135 | MP0001145_abnormal_male_reproductive | 0.82612081 |
| 136 | MP0001663_abnormal_digestive_system | 0.81494754 |
| 137 | MP0010329_abnormal_lipoprotein_level | 0.81120268 |
| 138 | MP0000249_abnormal_blood_vessel | 0.80713245 |
| 139 | MP0003448_altered_tumor_morphology | 0.80658151 |
| 140 | MP0000653_abnormal_sex_gland | 0.80646487 |
| 141 | MP0009643_abnormal_urine_homeostasis | 0.79964431 |
| 142 | MP0002796_impaired_skin_barrier | 0.79885588 |
| 143 | MP0005384_cellular_phenotype | 0.77976341 |
| 144 | MP0005390_skeleton_phenotype | 0.77918505 |
| 145 | MP0002085_abnormal_embryonic_tissue | 0.77798856 |
| 146 | MP0004130_abnormal_muscle_cell | 0.77444810 |
| 147 | MP0010234_abnormal_vibrissa_follicle | 0.77427800 |
| 148 | MP0000313_abnormal_cell_death | 0.76723999 |
| 149 | MP0009765_abnormal_xenobiotic_induced | 0.76611335 |
| 150 | MP0005319_abnormal_enzyme/_coenzyme | 0.76247832 |
| 151 | MP0004381_abnormal_hair_follicle | 0.75157350 |
| 152 | MP0004043_abnormal_pH_regulation | 0.74607217 |
| 153 | MP0002086_abnormal_extraembryonic_tissu | 0.74369209 |
| 154 | MP0003191_abnormal_cellular_cholesterol | 0.72761478 |
| 155 | MP0000537_abnormal_urethra_morphology | 0.72130744 |
| 156 | MP0004147_increased_porphyrin_level | 0.72018265 |
| 157 | MP0004808_abnormal_hematopoietic_stem | 0.71682473 |
| 158 | MP0000343_altered_response_to | 0.71660657 |
| 159 | MP0005375_adipose_tissue_phenotype | 0.70085091 |
| 160 | MP0000604_amyloidosis | 0.69860056 |
| 161 | MP0004510_myositis | 0.69817027 |
| 162 | MP0005058_abnormal_lysosome_morphology | 0.69391220 |
| 163 | MP0005174_abnormal_tail_pigmentation | 0.68093725 |
| 164 | MP0002136_abnormal_kidney_physiology | 0.67620010 |
| 165 | MP0001849_ear_inflammation | 0.67256460 |
| 166 | MP0002269_muscular_atrophy | 0.67093526 |
| 167 | MP0003868_abnormal_feces_composition | 0.66902414 |
| 168 | MP0002019_abnormal_tumor_incidence | 0.66787828 |
| 169 | MP0008004_abnormal_stomach_pH | 0.66666055 |
| 170 | MP0005266_abnormal_metabolism | 0.65582749 |
| 171 | MP0001661_extended_life_span | 0.65490163 |
| 172 | MP0002161_abnormal_fertility/fecundity | 0.64832477 |
| 173 | MP0005397_hematopoietic_system_phenotyp | 0.62795930 |
| 174 | MP0001545_abnormal_hematopoietic_system | 0.62795930 |
| 175 | MP0009333_abnormal_splenocyte_physiolog | 0.62654520 |
| 176 | MP0001119_abnormal_female_reproductive | 0.62325733 |
| 177 | MP0006036_abnormal_mitochondrial_physio | 0.61679476 |
| 178 | MP0005408_hypopigmentation | 0.61184286 |
| 179 | MP0009115_abnormal_fat_cell | 0.60449873 |
| 180 | MP0005083_abnormal_biliary_tract | 0.60185869 |
| 181 | MP0003795_abnormal_bone_structure | 0.59502882 |
| 182 | MP0000371_diluted_coat_color | 0.58931213 |
| 183 | MP0002009_preneoplasia | 0.57746703 |
| 184 | MP0004484_altered_response_of | 0.56689606 |
| 185 | MP0002332_abnormal_exercise_endurance | 0.55948821 |
| 186 | MP0005167_abnormal_blood-brain_barrier | 0.54485295 |
| 187 | MP0006054_spinal_hemorrhage | 0.53755096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.91965089 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.91519821 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.88893641 |
| 4 | Myositis (HP:0100614) | 4.80842233 |
| 5 | Breast hypoplasia (HP:0003187) | 4.80343132 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.76816921 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.61088320 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.52724475 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.47566239 |
| 10 | Optic neuritis (HP:0100653) | 4.47566239 |
| 11 | Orchitis (HP:0100796) | 4.43436092 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.42190263 |
| 13 | Rough bone trabeculation (HP:0100670) | 4.22618472 |
| 14 | T lymphocytopenia (HP:0005403) | 4.13244470 |
| 15 | Proximal tubulopathy (HP:0000114) | 4.10184405 |
| 16 | Carpal bone hypoplasia (HP:0001498) | 4.04919517 |
| 17 | Abnormality of T cell number (HP:0011839) | 4.04640990 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.97097642 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.95619334 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.95619334 |
| 21 | Ureteral duplication (HP:0000073) | 3.90729108 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.87210037 |
| 23 | Megaloblastic anemia (HP:0001889) | 3.85343455 |
| 24 | Meningitis (HP:0001287) | 3.82480339 |
| 25 | Cerebral hypomyelination (HP:0006808) | 3.77549434 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.74995663 |
| 27 | Nausea (HP:0002018) | 3.69478397 |
| 28 | Vasculitis (HP:0002633) | 3.69155246 |
| 29 | Recurrent skin infections (HP:0001581) | 3.61909850 |
| 30 | Birth length less than 3rd percentile (HP:0003561) | 3.59400774 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 3.57660841 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.47332420 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.46951355 |
| 34 | Encephalitis (HP:0002383) | 3.46365420 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46154710 |
| 36 | Hyperglycinuria (HP:0003108) | 3.44246784 |
| 37 | Ileus (HP:0002595) | 3.44054765 |
| 38 | Abnormality of T cells (HP:0002843) | 3.41752702 |
| 39 | Recurrent viral infections (HP:0004429) | 3.36258164 |
| 40 | Hemoptysis (HP:0002105) | 3.30981267 |
| 41 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.30572013 |
| 42 | Abnormality of the umbilical cord (HP:0010881) | 3.29662102 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 3.22387966 |
| 44 | Obstructive lung disease (HP:0006536) | 3.18587529 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18587529 |
| 46 | Secondary amenorrhea (HP:0000869) | 3.11439580 |
| 47 | Leukocytosis (HP:0001974) | 3.10124571 |
| 48 | Keratoconjunctivitis (HP:0001096) | 3.09780872 |
| 49 | Abnormal trabecular bone morphology (HP:0100671) | 3.08242812 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 3.05240027 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.05240027 |
| 52 | Pustule (HP:0200039) | 3.01677157 |
| 53 | Gingival bleeding (HP:0000225) | 2.97827729 |
| 54 | Chest pain (HP:0100749) | 2.96754715 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.96213149 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.95438717 |
| 57 | Multiple enchondromatosis (HP:0005701) | 2.95272219 |
| 58 | Progressive muscle weakness (HP:0003323) | 2.93467844 |
| 59 | Premature ovarian failure (HP:0008209) | 2.91626341 |
| 60 | Patent foramen ovale (HP:0001655) | 2.90532140 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.88575702 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.88575702 |
| 63 | Hyperglycinemia (HP:0002154) | 2.87623763 |
| 64 | Eosinophilia (HP:0001880) | 2.84712196 |
| 65 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.82050095 |
| 66 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.81848550 |
| 67 | IgG deficiency (HP:0004315) | 2.81359937 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.80985516 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.79199366 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.77104690 |
| 71 | Gingivitis (HP:0000230) | 2.76975705 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.75940782 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.74138305 |
| 74 | Increased IgE level (HP:0003212) | 2.74106548 |
| 75 | Urticaria (HP:0001025) | 2.73827501 |
| 76 | Epistaxis (HP:0000421) | 2.73494523 |
| 77 | Abnormality of the anterior horn cell (HP:0006802) | 2.71900961 |
| 78 | Degeneration of anterior horn cells (HP:0002398) | 2.71900961 |
| 79 | Methylmalonic aciduria (HP:0012120) | 2.69873751 |
| 80 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.66428520 |
| 81 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.66428520 |
| 82 | Single umbilical artery (HP:0001195) | 2.66428520 |
| 83 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.65857652 |
| 84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.65857652 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.65857652 |
| 86 | Abnormality of alanine metabolism (HP:0010916) | 2.61297871 |
| 87 | Hyperalaninemia (HP:0003348) | 2.61297871 |
| 88 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.61297871 |
| 89 | Abnormality of serum amino acid levels (HP:0003112) | 2.60990686 |
| 90 | Hyperactive renin-angiotensin system (HP:0000841) | 2.60238653 |
| 91 | Colitis (HP:0002583) | 2.58877052 |
| 92 | Arterial thrombosis (HP:0004420) | 2.58674492 |
| 93 | Absent radius (HP:0003974) | 2.58632505 |
| 94 | Hypobetalipoproteinemia (HP:0003563) | 2.57940315 |
| 95 | Abnormality of vitamin B metabolism (HP:0004340) | 2.57317594 |
| 96 | Poor head control (HP:0002421) | 2.56026461 |
| 97 | Progressive external ophthalmoplegia (HP:0000590) | 2.54010931 |
| 98 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.53348702 |
| 99 | Prolonged neonatal jaundice (HP:0006579) | 2.52771128 |
| 100 | Glycosuria (HP:0003076) | 2.52456880 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 2.52456880 |
| 102 | Impulsivity (HP:0100710) | 2.50521763 |
| 103 | Episodic fever (HP:0001954) | 2.50125528 |
| 104 | Lymphopenia (HP:0001888) | 2.49612837 |
| 105 | Gastrointestinal inflammation (HP:0004386) | 2.49543469 |
| 106 | Abnormality of eosinophils (HP:0001879) | 2.47344266 |
| 107 | Pulmonary embolism (HP:0002204) | 2.47105437 |
| 108 | Cellulitis (HP:0100658) | 2.46861139 |
| 109 | Increased IgM level (HP:0003496) | 2.46634001 |
| 110 | Autoimmune thrombocytopenia (HP:0001973) | 2.44221484 |
| 111 | Agnosia (HP:0010524) | 2.44031842 |
| 112 | Spinal muscular atrophy (HP:0007269) | 2.42623297 |
| 113 | Patellar aplasia (HP:0006443) | 2.42541321 |
| 114 | Absent forearm bone (HP:0003953) | 2.40500230 |
| 115 | Aplasia involving forearm bones (HP:0009822) | 2.40500230 |
| 116 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.39269490 |
| 117 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.39092534 |
| 118 | Anorexia (HP:0002039) | 2.38630066 |
| 119 | Absent hand (HP:0004050) | 2.37851867 |
| 120 | Hyperglycemia (HP:0003074) | 2.37562556 |
| 121 | Hypochromic anemia (HP:0001931) | 2.37218481 |
| 122 | Increased cerebral lipofuscin (HP:0011813) | 2.35926603 |
| 123 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.35909731 |
| 124 | Abnormality of B cell number (HP:0010975) | 2.35875035 |
| 125 | Congenital malformation of the right heart (HP:0011723) | 2.35545775 |
| 126 | Double outlet right ventricle (HP:0001719) | 2.35545775 |
| 127 | Hematochezia (HP:0002573) | 2.34549959 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34233379 |
| 129 | Granulocytopenia (HP:0001913) | 2.33828860 |
| 130 | Chronic diarrhea (HP:0002028) | 2.33316740 |
| 131 | Thyroiditis (HP:0100646) | 2.33262752 |
| 132 | Congenital, generalized hypertrichosis (HP:0004540) | 2.32584353 |
| 133 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30267432 |
| 134 | Hypergammaglobulinemia (HP:0010702) | 2.29744086 |
| 135 | Sparse eyelashes (HP:0000653) | 2.28378868 |
| 136 | Generalized aminoaciduria (HP:0002909) | 2.28253474 |
| 137 | CNS hypomyelination (HP:0003429) | 2.26789138 |
| 138 | Abnormality of vitamin metabolism (HP:0100508) | 2.25980442 |
| 139 | Homocystinuria (HP:0002156) | 2.25529135 |
| 140 | Abnormality of homocysteine metabolism (HP:0010919) | 2.25529135 |
| 141 | Abnormality of the prostate (HP:0008775) | 2.25506392 |
| 142 | Gangrene (HP:0100758) | 2.24388563 |
| 143 | Gastrointestinal stroma tumor (HP:0100723) | 2.23813528 |
| 144 | Severe combined immunodeficiency (HP:0004430) | 2.20517813 |
| 145 | Chronic sinusitis (HP:0011109) | 2.18680428 |
| 146 | Chronic otitis media (HP:0000389) | 2.18187551 |
| 147 | Decreased circulating renin level (HP:0003351) | 2.18043816 |
| 148 | Personality changes (HP:0000751) | 2.17693461 |
| 149 | Microretrognathia (HP:0000308) | 2.17585918 |
| 150 | Lethargy (HP:0001254) | 2.17309082 |
| 151 | Death in infancy (HP:0001522) | 2.16112682 |
| 152 | CNS demyelination (HP:0007305) | 2.15750478 |
| 153 | Petechiae (HP:0000967) | 2.15367782 |
| 154 | Bundle branch block (HP:0011710) | 2.14330165 |
| 155 | Osteomyelitis (HP:0002754) | 2.12673628 |
| 156 | Abnormal spermatogenesis (HP:0008669) | 2.11764874 |
| 157 | Abnormality of the pericardium (HP:0001697) | 2.11440451 |
| 158 | Meckel diverticulum (HP:0002245) | 2.10576095 |
| 159 | Restrictive lung disease (HP:0002091) | 2.09601962 |
| 160 | Methylmalonic acidemia (HP:0002912) | 2.08871506 |
| 161 | Hypochromic microcytic anemia (HP:0004840) | 2.06277151 |
| 162 | Peritonitis (HP:0002586) | 2.06236589 |
| 163 | Microcytic anemia (HP:0001935) | 2.05496672 |
| 164 | Macrocytic anemia (HP:0001972) | 2.02804481 |
| 165 | Papilloma (HP:0012740) | 2.01492501 |
| 166 | Verrucae (HP:0200043) | 2.01492501 |
| 167 | Short clavicles (HP:0000894) | 2.01138095 |
| 168 | Unsteady gait (HP:0002317) | 2.00682302 |
| 169 | Male infertility (HP:0003251) | 2.00585819 |
| 170 | Testicular atrophy (HP:0000029) | 2.00333176 |
| 171 | Horseshoe kidney (HP:0000085) | 2.00287819 |
| 172 | Hypolipoproteinemia (HP:0010981) | 1.99726693 |
| 173 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99507833 |
| 174 | Stomach cancer (HP:0012126) | 1.99292902 |
| 175 | Athetosis (HP:0002305) | 1.98149676 |
| 176 | Keratitis (HP:0000491) | 1.96605608 |
| 177 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.95822947 |
| 178 | Polyneuropathy (HP:0001271) | 1.95585839 |
| 179 | Increased circulating renin level (HP:0000848) | 1.94369171 |
| 180 | Hepatic necrosis (HP:0002605) | 1.93221990 |
| 181 | Recurrent sinusitis (HP:0011108) | 1.93146833 |
| 182 | IgM deficiency (HP:0002850) | 1.92879817 |
| 183 | Fused cervical vertebrae (HP:0002949) | 1.92516501 |
| 184 | Emphysema (HP:0002097) | 1.92437438 |
| 185 | Viral hepatitis (HP:0006562) | 1.91883772 |
| 186 | Hypoglycemic coma (HP:0001325) | 1.91792218 |
| 187 | Skin rash (HP:0000988) | 1.91692504 |
| 188 | Sepsis (HP:0100806) | 1.91290903 |
| 189 | Fibular aplasia (HP:0002990) | 1.91020881 |
| 190 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.89916527 |
| 191 | Breast aplasia (HP:0100783) | 1.89658668 |
| 192 | Stenosis of the external auditory canal (HP:0000402) | 1.88085186 |
| 193 | Neoplasm of the pancreas (HP:0002894) | 1.87976433 |
| 194 | Malnutrition (HP:0004395) | 1.87466482 |
| 195 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.86763842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.32389636 |
| 2 | EPHA2 | 4.83809666 |
| 3 | WEE1 | 4.64705347 |
| 4 | RIPK4 | 3.66978131 |
| 5 | MAP4K1 | 3.59268474 |
| 6 | PLK4 | 3.44860332 |
| 7 | STK16 | 3.39868929 |
| 8 | BLK | 3.39758408 |
| 9 | PNCK | 3.31768682 |
| 10 | EIF2AK1 | 3.17753012 |
| 11 | IRAK3 | 3.16491627 |
| 12 | TXK | 3.05776834 |
| 13 | TTK | 2.98073957 |
| 14 | TAOK3 | 2.92751600 |
| 15 | NME1 | 2.88741105 |
| 16 | ZAK | 2.78759005 |
| 17 | TYK2 | 2.63301645 |
| 18 | NEK1 | 2.31737378 |
| 19 | IKBKE | 2.26382883 |
| 20 | MARK1 | 2.23164190 |
| 21 | MAP3K14 | 2.21823152 |
| 22 | AKT3 | 2.15117007 |
| 23 | TSSK6 | 2.11511400 |
| 24 | JAK3 | 2.08509056 |
| 25 | CSK | 2.07093964 |
| 26 | SYK | 2.03713126 |
| 27 | ZAP70 | 2.00749600 |
| 28 | FES | 1.97872841 |
| 29 | BTK | 1.95270370 |
| 30 | ARAF | 1.88897532 |
| 31 | JAK1 | 1.87046685 |
| 32 | ERN1 | 1.84634770 |
| 33 | SRPK1 | 1.84150850 |
| 34 | KIT | 1.83410761 |
| 35 | NUAK1 | 1.76232279 |
| 36 | MAP2K3 | 1.75414161 |
| 37 | BRAF | 1.71705465 |
| 38 | IKBKB | 1.69255524 |
| 39 | TNK2 | 1.67005417 |
| 40 | TEC | 1.66134708 |
| 41 | EIF2AK3 | 1.65387934 |
| 42 | TBK1 | 1.59434397 |
| 43 | BMPR2 | 1.56988636 |
| 44 | RPS6KB2 | 1.51516484 |
| 45 | BRSK2 | 1.50925093 |
| 46 | HCK | 1.50275359 |
| 47 | LYN | 1.49729926 |
| 48 | MAP3K13 | 1.47149148 |
| 49 | ITK | 1.47002169 |
| 50 | PRKCI | 1.42256222 |
| 51 | PIK3CG | 1.38947484 |
| 52 | PLK3 | 1.35102933 |
| 53 | LCK | 1.34309885 |
| 54 | PLK1 | 1.33977083 |
| 55 | NEK2 | 1.25275697 |
| 56 | CSF1R | 1.24644386 |
| 57 | PDK3 | 1.21562021 |
| 58 | PDK4 | 1.21562021 |
| 59 | MARK3 | 1.18752088 |
| 60 | MAP3K11 | 1.15111110 |
| 61 | JAK2 | 1.14482410 |
| 62 | CHEK2 | 1.12969957 |
| 63 | TESK2 | 1.11573433 |
| 64 | FGFR3 | 1.11025279 |
| 65 | LATS2 | 1.10966877 |
| 66 | ADRBK2 | 1.10961935 |
| 67 | TGFBR2 | 1.09193960 |
| 68 | MAP3K3 | 1.09193882 |
| 69 | PRPF4B | 1.07970096 |
| 70 | PDK2 | 1.07362439 |
| 71 | NEK9 | 1.06789570 |
| 72 | STK24 | 1.04522118 |
| 73 | STK38L | 1.03893504 |
| 74 | FGR | 1.03440523 |
| 75 | LATS1 | 1.00737484 |
| 76 | MAP3K8 | 1.00631432 |
| 77 | CAMKK2 | 1.00319811 |
| 78 | AURKA | 1.00258859 |
| 79 | EPHB1 | 1.00066144 |
| 80 | IRAK4 | 1.00004161 |
| 81 | MATK | 0.99168991 |
| 82 | BRSK1 | 0.97396417 |
| 83 | MST4 | 0.96082857 |
| 84 | EPHA4 | 0.94158588 |
| 85 | GRK7 | 0.93523017 |
| 86 | FRK | 0.93334879 |
| 87 | PBK | 0.93206054 |
| 88 | ABL2 | 0.92499688 |
| 89 | IRAK2 | 0.90855268 |
| 90 | PTK2B | 0.90622897 |
| 91 | MST1R | 0.90557067 |
| 92 | CHUK | 0.90078162 |
| 93 | MAP3K1 | 0.86341098 |
| 94 | HIPK2 | 0.86335574 |
| 95 | PRKCQ | 0.86258666 |
| 96 | PIM2 | 0.84738329 |
| 97 | AURKB | 0.83707399 |
| 98 | CDC42BPA | 0.81398773 |
| 99 | PRKD2 | 0.78060702 |
| 100 | TRPM7 | 0.77570230 |
| 101 | STK10 | 0.75802569 |
| 102 | EPHA3 | 0.75743342 |
| 103 | MAP2K2 | 0.75592535 |
| 104 | CAMK2B | 0.72830654 |
| 105 | GRK1 | 0.71182134 |
| 106 | MAPK7 | 0.71090906 |
| 107 | SIK2 | 0.69369582 |
| 108 | PAK4 | 0.69258764 |
| 109 | PAK1 | 0.68346713 |
| 110 | MAP3K7 | 0.67991947 |
| 111 | PDK1 | 0.67102851 |
| 112 | MAP3K2 | 0.65677177 |
| 113 | IRAK1 | 0.64892703 |
| 114 | FGFR4 | 0.64298145 |
| 115 | MKNK2 | 0.64044760 |
| 116 | TLK1 | 0.62962659 |
| 117 | TAOK2 | 0.58633987 |
| 118 | MAPK11 | 0.56999348 |
| 119 | CAMK2G | 0.56253891 |
| 120 | DYRK3 | 0.55583918 |
| 121 | SGK2 | 0.55574548 |
| 122 | ABL1 | 0.55191385 |
| 123 | CSNK1G2 | 0.52612274 |
| 124 | EIF2AK2 | 0.51687884 |
| 125 | SIK3 | 0.51534301 |
| 126 | MAPK12 | 0.51483257 |
| 127 | PLK2 | 0.48830183 |
| 128 | MOS | 0.48183741 |
| 129 | TAOK1 | 0.47752325 |
| 130 | MAP2K1 | 0.46208058 |
| 131 | CHEK1 | 0.44891974 |
| 132 | NME2 | 0.44511497 |
| 133 | WNK1 | 0.43885215 |
| 134 | DYRK2 | 0.43850797 |
| 135 | PDPK1 | 0.42921038 |
| 136 | CAMK2D | 0.42211990 |
| 137 | STK3 | 0.41756025 |
| 138 | SGK3 | 0.41422166 |
| 139 | ACVR1B | 0.41415387 |
| 140 | CDK4 | 0.40773809 |
| 141 | FYN | 0.40053143 |
| 142 | STK4 | 0.39852566 |
| 143 | MKNK1 | 0.39707604 |
| 144 | MAPKAPK2 | 0.39210442 |
| 145 | YES1 | 0.39162498 |
| 146 | ADRBK1 | 0.39138315 |
| 147 | CSNK1E | 0.38867741 |
| 148 | VRK1 | 0.38657029 |
| 149 | CSNK2A1 | 0.38016450 |
| 150 | ATR | 0.36780927 |
| 151 | KDR | 0.36706106 |
| 152 | RPS6KA6 | 0.36600647 |
| 153 | CDK2 | 0.35404918 |
| 154 | CDC7 | 0.34342535 |
| 155 | STK11 | 0.33536791 |
| 156 | PDGFRB | 0.33159824 |
| 157 | MAP3K9 | 0.32997611 |
| 158 | ALK | 0.32739230 |
| 159 | LRRK2 | 0.32594055 |
| 160 | OXSR1 | 0.32118198 |
| 161 | RAF1 | 0.30797531 |
| 162 | NLK | 0.30583610 |
| 163 | GRK5 | 0.29564058 |
| 164 | MARK2 | 0.29179570 |
| 165 | CCNB1 | 0.27607194 |
| 166 | MAPK3 | 0.26898904 |
| 167 | SCYL2 | 0.26535672 |
| 168 | CSNK1A1 | 0.25680267 |
| 169 | MAP3K5 | 0.25671271 |
| 170 | MELK | 0.24454550 |
| 171 | CSNK2A2 | 0.23969140 |
| 172 | PRKCG | 0.20876938 |
| 173 | PRKAA2 | 0.20794810 |
| 174 | CDK1 | 0.19999439 |
| 175 | GRK6 | 0.17253697 |
| 176 | ILK | 0.16025176 |
| 177 | MAP2K6 | 0.15761930 |
| 178 | CDK7 | 0.14174450 |
| 179 | TESK1 | 0.14080477 |
| 180 | MAP3K6 | 0.11913819 |
| 181 | PIM1 | 0.11469822 |
| 182 | STK38 | 0.10586110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 6.78911099 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.31364462 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.31131170 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.24541352 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.12049194 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.95831696 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.91598681 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.87932389 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.86676174 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82298836 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.77043028 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.75563345 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.74357841 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.68620512 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.67476899 |
| 16 | RNA transport_Homo sapiens_hsa03013 | 2.55401753 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54330238 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.48356796 |
| 19 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.41877681 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.41266128 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29866589 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 2.22739688 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 2.14174762 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.13257099 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06523366 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03538675 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00886968 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.99101717 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95673630 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.93783709 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.90361125 |
| 32 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.85113456 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82686996 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79312646 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.76844061 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75806484 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.74356044 |
| 38 | Ribosome_Homo sapiens_hsa03010 | 1.74312779 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74071501 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.69462887 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.67940273 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67095040 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.65763392 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.64588959 |
| 45 | Cell cycle_Homo sapiens_hsa04110 | 1.61700219 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.61325250 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61055617 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.60670557 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.60072161 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57338294 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50614040 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47833812 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.47137408 |
| 54 | Malaria_Homo sapiens_hsa05144 | 1.47100457 |
| 55 | Base excision repair_Homo sapiens_hsa03410 | 1.46403983 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.45941440 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 1.44754899 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.43285738 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40848156 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 1.40145243 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.39397663 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38502545 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.36194272 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.35548300 |
| 65 | Basal transcription factors_Homo sapiens_hsa03022 | 1.31330285 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.30772811 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30744519 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29819281 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29583087 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25846423 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25566312 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.23727623 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20733216 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20292618 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19694726 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18913057 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16687931 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 1.16348272 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13487685 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10463836 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06140723 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04693597 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 1.03661849 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02402198 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00595069 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.00481807 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.99740226 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.99692813 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98599766 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.98511984 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97075423 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.96352630 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92446909 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88220561 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87586241 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87267875 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85460282 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85442336 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84382207 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80363106 |
| 101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79923548 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79457049 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.75749831 |
| 104 | RNA degradation_Homo sapiens_hsa03018 | 0.74108818 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74019935 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.71815466 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70268369 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69319875 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66949876 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66281781 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65824728 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65113188 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64579299 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61522627 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.61263469 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59715859 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59085200 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58572330 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58456659 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53159876 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52599689 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52552161 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52175831 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52087608 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51397165 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48293523 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47932953 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47495187 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47434651 |
| 130 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47100089 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.46132713 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.46013805 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.45827868 |
| 134 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44104126 |
| 135 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43470355 |
| 136 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41854625 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41306175 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41194980 |
| 139 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40299401 |
| 140 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39951233 |
| 141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39483549 |
| 142 | ABC transporters_Homo sapiens_hsa02010 | 0.39227981 |
| 143 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38850944 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38550086 |
| 145 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37954617 |
| 146 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37527712 |
| 147 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37247535 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36466470 |
| 149 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.36346640 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36070718 |
| 151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36065986 |
| 152 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34898771 |
| 153 | Tight junction_Homo sapiens_hsa04530 | 0.34755938 |
| 154 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34522463 |
| 155 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34370415 |
| 156 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34025052 |
| 157 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32545427 |
| 158 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32153576 |
| 159 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31503625 |
| 160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30500314 |
| 161 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28069798 |
| 162 | Prostate cancer_Homo sapiens_hsa05215 | 0.26873199 |
| 163 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26581864 |
| 164 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25846662 |
| 165 | Endocytosis_Homo sapiens_hsa04144 | 0.25537586 |
| 166 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24663185 |
| 167 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23736846 |
| 168 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22940246 |
| 169 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22788775 |
| 170 | Amoebiasis_Homo sapiens_hsa05146 | 0.22781350 |
| 171 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.22668145 |
| 172 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21640837 |
| 173 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21427943 |
| 174 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19089811 |
| 175 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.18954318 |
| 176 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.18191007 |
| 177 | Bile secretion_Homo sapiens_hsa04976 | 0.15093988 |
| 178 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.11384610 |
| 179 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.10448219 |
| 180 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.10285061 |
| 181 | Protein export_Homo sapiens_hsa03060 | 0.09849566 |
| 182 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.09176080 |
| 183 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.07653602 |
| 184 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.07275826 |
| 185 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.07088779 |
| 186 | Peroxisome_Homo sapiens_hsa04146 | 0.05941339 |
| 187 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.04153110 |
| 188 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04032839 |
| 189 | Lysosome_Homo sapiens_hsa04142 | 0.03637006 |

